Part 2: Could active adult housing help solve the middle-market affordability challenge?
By
Jim Moore
Oct 05, 2021
Beside value-engineering the physical product, reduced operating expenses also can play a role.
From transportation to housekeeping, MA plans moving further into the home in 2022
By
Diane Eastabrook
Oct 05, 2021
Medicare Advantage plans are moving more benefits into the home in 2022. In-home primary care, transportation, meals and in-home support are just a handful of new benefits private insurers are offering...
Acute myocarditis rare after COVID-19 mRNA vaccination in adults
Oct 04, 2021
All cases in this study occurred among men, with a median age of 25 years.
Colorectal cancer diagnoses plummeted during the pandemic
Oct 04, 2021
Fewer cases of colorectal cancer were identified through screening; more patients had serious complications at the time of diagnosis.
Sinceri CEO discusses rebranding, the future, and the importance of listening to employees
By
Lois A. Bowers
Oct 04, 2021
Sinceri Senior Living CEO Chris Belford shares insights as JEA changes its name to Sinceri and the industry looks beyond the pandemic.
Tips for caregivers during Mental Health Screening Month
By
Caroline Szachnowski
Oct 04, 2021
The COVID-19 pandemic has taken a toll on caregivers. Work and personal stress and fatigue have resulted in another crisis in the United States — one related to mental exhaustion. Just last week, a study...
Compassion, empathy, integrity and humility make Enlivant ‘Great Place to Work,’ CEO says
By
Kathleen Steele Gaivin
Oct 04, 2021
Guill is optimistic about the future of senior living and care.
States navigate implementing COVID-19 vaccine requirements
By
Kathleen Steele Gaivin
Oct 04, 2021
Today is the day that Connecticut’s long-term workers and other workers employed by the state are required to comply with a COVID-19 vaccine mandate or agree to regular testing. The deadline was postponed...
REGEN-COV reduces risk for COVID-19 hospitalization, death
Oct 01, 2021
Among outpatients with COVID-19 at high risk, the risk for hospitalization and death was reduced with the monoclonal antibody combo versus placebo.
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.